Inhibikase Therapeutics, Inc.
IKT
Revenue
0.00
0.000.00%
3 Months ChangeAssets
98.60M
▲94.22M▲2152.75%
3 Months ChangeLiabilities
3.73M
▼-1.17M▼-23.92%
3 Months ChangeFree Cash Flow
-19.15M
▼-1.05M▼-5.79%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-22
Form 8-K
ID: 0001193125-24-240603
2024-10-10
Form 8-K
ID: 0001193125-24-236039
2024-10-09
Form 8-K
ID: 0001193125-24-234814
2024-08-14
Form 10-Q
ID: 0000950170-24-097022
2024-08-06
Form 8-K
ID: 0001193125-24-194177
2024-06-10
Form 8-K
ID: 0001193125-24-158318
2024-05-20
Form 8-K
ID: 0001193125-24-142317
2024-05-15
Form 10-Q
ID: 0000950170-24-060579
2024-04-30
Form 8-K
ID: 0001193125-24-123758
2024-04-19
Form 8-K
ID: 0001193125-24-101292